Could Absci’s ABS-201 open a new biologic pathway for androgenetic alopecia treatment?
Absci’s interim ABS-201 data strengthen the early case for a long-acting PRLR antibody in androgenetic alopecia and AI-designed biologics.
Pharma & Biotech
Features & Analysis
Is endometriosis diagnosis finally moving beyond surgery after years of missed symptoms?
Endometriosis testing is escaping the surgery-first era. Saliva, blood and imaging tools now face the harder test: clinical utility.